# Invesco NASDAQ-100 Equal Weight UCITS ETF AccumUSD (EWQX)

**Page:** https://fundology.uk/fund/ewqx · ISIN IE000L2SA8K5

## At a glance

> Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.

As of 13/11/2026, EWQX (Invesco NASDAQ-100 Equal Weight UCITS ETF AccumUSD, ISIN IE000L2SA8K5) closed at £5.91 on the London Stock Exchange. Its ongoing charge is 0.20% a year (about £20 on £10,000). Over the three years to 13/11/2026 its price changed by +45.8%, or +31.7% after UK CPIH inflation.

## Summary

Invesco NASDAQ-100 Equal Weight UCITS ETF AccumUSD is an exchange-traded fund (ETF) from Invesco, launched in 2023. It tracks the NASDAQ-100 Equal Weighted Index — the 100 largest non-financial companies on the US Nasdaq exchange, weighted heavily towards technology. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.2% a year — about £20 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.

Latest close: **£5.91** (13/11/2026).

## Key facts

| Fact | Value |
|---|---|
| Ticker (LSE) | EWQX |
| ISIN | IE000L2SA8K5 |
| Also listed as | IEWQ (London Stock Exchange, US dollars), EWQA (Xetra, euros) |
| Category | US shares |
| Type | ETF |
| Provider | Invesco |
| Tracks | NASDAQ-100 Equal Weighted Index |
| Income | Accumulating |
| Ongoing charge | 0.20% a year (£20 per £10,000) |
| Fund size | £94.1m |
| Launched | 2023 |
| Domicile | Ireland |
| UK reporting fund status | Yes — on HMRC’s list of reporting funds (list of 02/11/2026); reporting fund since 10/07/2023 |

## Past returns (periods to 13/11/2026)

After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after UK CPIH inflation.

| Window | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 1 year | +13.81% | +9.78% | income reinvested |
| 3 years | +45.79% | +31.72% | price only |

Returns: as reported (delayed data) and worked out from recorded daily closes. Inflation: UK CPIH, latest month published.

## Calendar-year returns

Calendar-year returns of Invesco NASDAQ-100 Equal Weight UCITS ETF AccumUSD in pounds (price, with income reinvested in the fund): 2024 +10.6%, 2025 +4.1%; 2026 to 13/11/2026 +15.5%. Returns of Invesco NASDAQ-100 Equal Weight UCITS ETF AccumUSD in pounds (price, with income reinvested in the fund) over the 12 months to 30/09/2026: +19.7%; to 30/09/2025: +13.5%; to 30/09/2024: +10.8%.

| Year | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 2024 | +10.6% | +6.9% | Price |
| 2025 | +4.1% | +0.6% | Price |
| 2026 to 13/11/2026 | +15.5% | +11.8% | Price |

## Risk metrics

| Window | Volatility | Max drawdown |
|---|---|---|
| 1 year | 14.17% | -8.51% |
| 3 years | 15.30% | -19.14% |

## Largest fall

Volatility of Invesco NASDAQ-100 Equal Weight UCITS ETF AccumUSD in pounds, annualised from weekly returns to 13/11/2026: 14.2% over 1 year, 15.3% over 3 years. Largest fall in the price of Invesco NASDAQ-100 Equal Weight UCITS ETF AccumUSD since July 2023, in pounds: −19.1% from 14/02/2025 to 11/04/2025. The lowest 12-month return of Invesco NASDAQ-100 Equal Weight UCITS ETF AccumUSD in pounds (price, with income reinvested in the fund) since July 2023 was −10.3% (12 months to 11/04/2025); the highest was +31.2% (12 months to 19/06/2026). On 13/11/2026 the price of Invesco NASDAQ-100 Equal Weight UCITS ETF AccumUSD was 5.2% below its highest weekly close since July 2023 (09/10/2026), in pounds.

## Charges compared with similar funds

Ongoing charge of Invesco NASDAQ-100 Equal Weight UCITS ETF AccumUSD 0.20% a year. Compared on 14/11/2026, 85 of the 254 other US share funds charge more, 44 the same and 125 less (share classes counted once).

## Charges & eligibility

- Ongoing charges figure (OCF): **0.20%** per year
- Stocks and shares ISA eligible: usually (check with your platform)
- SIPP eligible: usually (check with your provider)
- ISA and SIPP mean the kind of product usually qualifies under HMRC rules. We do not check each platform’s list — each provider decides which funds it offers. Crypto ETNs have not qualified for a stocks and shares ISA since 06/04/2026, and overseas funds that are not UK-recognised UCITS, such as Swiss ETFs, do not usually qualify.

## What it holds

As of 12/11/2026, EWQX holds 102 positions, according to its published holdings. The largest is Moderna at 1.35% of the fund; the ten largest make up 12.7%.

### Top holdings

Largest positions (as of 12/11/2026), as a percentage of the whole fund:

| # | Holding | Ticker | Weight |
|---|---|---|---|
| 1 | Moderna | [MRNA](https://fundology.uk/stock/MRNA) | 1.35% |
| 2 | Applovin · Class A | [APP](https://fundology.uk/stock/APP) | 1.31% |
| 3 | IDEXX Laboratories | [IDXX](https://fundology.uk/stock/IDXX) | 1.30% |
| 4 | Advanced Micro Devices | [AMD](https://fundology.uk/stock/AMD) | 1.29% |
| 5 | Marriott International · Class A | [MAR](https://fundology.uk/stock/MAR) | 1.29% |
| 6 | Walmart | [WMT](https://fundology.uk/stock/WMT) | 1.25% |
| 7 | Regeneron Pharmaceuticals | [REGN](https://fundology.uk/stock/REGN) | 1.24% |
| 8 | Texas Instruments | [TXN](https://fundology.uk/stock/TXN) | 1.24% |
| 9 | NXP Semiconductors | [NXPI](https://fundology.uk/stock/NXPI) | 1.23% |
| 10 | Intuitive Surgical | [ISRG](https://fundology.uk/stock/ISRG) | 1.21% |

## Where it invests

Shares of the whole fund. Bonds, cash and positions without a classification are shown as they come, not guessed.

### By sector

As published for the fund, as of 12/11/2026.

| Sector | Weight |
|---|---|
| Information Technology | 39.0% |
| Industrials | 14.2% |
| Health Care | 11.3% |
| Consumer Discretionary | 11.0% |
| Communication Services | 8.2% |
| Consumer Staples | 7.9% |
| Utilities | 4.3% |
| Energy | 1.7% |
| Other sectors | 2.3% |

### By country

As published for the fund, as of 12/11/2026.

| Country | Weight |
|---|---|
| United States | 92.1% |
| Netherlands | 2.9% |
| Canada | 2.1% |
| United Kingdom | 1.1% |
| China | 1.0% |
| Brazil | 0.8% |

All 102 holdings: https://fundology.uk/fund/ewqx/holdings

## Questions people ask

**What is the ongoing charge of EWQX?**

The ongoing charge of EWQX is 0.20% a year — about £20 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of Invesco NASDAQ-100 Equal Weight UCITS ETF AccumUSD 0.20% a year. Compared on 14/11/2026, 85 of the 254 other US share funds charge more, 44 the same and 125 less (share classes counted once).

**What does EWQX track?**

EWQX tracks the NASDAQ-100 Equal Weighted Index — the 100 largest non-financial companies on the US Nasdaq exchange, weighted heavily towards technology.

**Is EWQX accumulating or distributing?**

EWQX is accumulating: income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.

**What is the ISIN of EWQX?**

The ISIN of EWQX is IE000L2SA8K5. An ISIN identifies one exact share class of a fund; EWQX is its ticker on the London Stock Exchange. The same share class is also listed as IEWQ (London Stock Exchange, US dollars) and EWQA (Xetra, euros).

**What does EWQX hold?**

As of 12/11/2026, EWQX holds 102 positions, according to its published holdings. The largest is Moderna at 1.35% of the fund; the ten largest make up 12.7%. Its ten largest holdings are Moderna (1.35%), Applovin · Class A (1.31%), IDEXX Laboratories (1.30%), Advanced Micro Devices (1.29%), Marriott International · Class A (1.29%), Walmart (1.25%), Regeneron Pharmaceuticals (1.24%), Texas Instruments (1.24%), NXP Semiconductors (1.23%) and Intuitive Surgical (1.21%).

**What were EWQX’s returns in each of the last five years?**

Calendar-year returns of EWQX in pounds (price, with income reinvested in the fund): 2024 +10.6%, 2025 +4.1%; 2026 to 13/11/2026 +15.5%. Past performance is not a guide to future returns.

**How has EWQX done after inflation?**

Over the three years to 13/11/2026 EWQX’s price changed by +45.8%, or +31.7% after UK CPIH inflation. Past performance is not a guide to future returns.

---

We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments.

Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.